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Abstract Rapid advances in the ability to produce nano-
particles of uniform size, shape, and composition have started
a revolution in the sciences. Nano-sized structures herald
innovative technology with a wide range of potential
therapeutic and diagnostic applications. More than 1000
nanostructures have been reported, many with potential
medical applications, such as metallic-, dielectric-, magnetic-,
liposomal-, and carbon-based structures. Of these, noble
metallic nanoparticles are generating significant interest
because of their multifunctional capacity for novel methods
of laboratory-based diagnostics, in vivo clinical diagnostic
imaging, and therapeutic treatments. This review focuses on
recent advances in the applications of nanotechnology in head
and neck cancer, with special emphasis on the particularly
promising plasmonic gold nanotechnology.
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Introduction
Nanobiotechnology represents the convergence of multiple
scientific fields including chemistry, engineering, physics,
and molecular biology. Nanoparticles are generating a
revolution within the scientific community as the race to
develop clinically useful structures progresses. Elements
restricted to the nanoscale in various forms demonstrate
previously unseen physical properties (electronic, optical,
magnetic, catalytic) [1]. Due the appropriate size match and
facile surface chemistry allowing conjugation to biologi-
cally active molecules, several nanoparticles are potentially
exploitable for a wide range of applications in biology and
medicine. Nanotechnology has generated significant invest-
ment from the National Institutes of Health (NIH)/National
Cancer Institute and is expected to create a paradigm-shift
in the detection, treatment, and prevention of cancer [2].
A plethora of nanostructures have been described with
varying composition (eg, gold, iron oxide, carbon, dielec-
tric materials, molecular, liposomal) and shapes including
solid nanoparticles (eg, spheres, rods, triangles, cubes),
nanoshells (within inner and outer cores), nanocages,
nanowire, nanotubes, branched dendrimers, and polymeric
and organic lipid nanoparticles [3]. Inorganic nanoparticles
areparticularlyinteresting becauseoftheirunique electronic,
magnetic, optical, photothermal, or catalytic properties at the
nanoscale. Of the array of nanostructures currently available,
plasmonic gold nanoparticles are especially promising
because of their simple fabrication, multifunctional nature,
facile surface chemistry [3–6••], biodistribution properties,
and relatively low toxicity [7•, 8, 9].
Gold nanoparticles can be applied therapeutically for
photothermal therapy [3], intravascular drug/gene delivery
[10], and ionizing radiation enhancement [11]. This new
technology has impending clinical application toward head
and neck cancer as evidenced by the initiation of two phase
1 human trials investigating gold conjugated tumor necrosis
factor (TNF) treatment of solid tumors [12] and photo-
thermal therapy of refractory head and neck cancer [13]. A
discussion of gold nanotechnology provides a foundation to
understand the unique possibilities created by the emerging
nanosciences.
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Nanotechnology is expected to provide a range of devices
for diagnosis and treatment in medicine. On the size scale
of 1 to 200 nm, nanoparticles are well matched in size to
biologic molecules and structures found inside living cells
[14]. Typical mammalian cells range in size from 2000 nm
to 10,000 nm, whereas cellular organelles are about 100 nm
to 300 nm and intracellular proteins and molecules are
about 10 nm to 50 nm. Nanoparticles appear the appropriate
size range for imaging and manipulation at the molecular
level. The ability to control the nanoparticle surface
chemistry allows conjugation to various ligands for
interactions at the molecular level. Furthermore, gold
nanoparticles produce greatly enhanced spectral signals
that are detectable above the background noise of cells and
extracellular tissue.
Head and Neck Cancer: Room for Improvement
Cancer is the second-leading cause of mortality in the
United States, responsible for one in every four deaths [15].
Cancers of the head and neck—including the salivary
glands, thyroid, and the mucosal lining of the oral cavity,
pharynx, nasopharynx, and larynx—account for 2% to 6%
of all malignancies in the United States [16]. The mainstay
of treatment for head and neck cancer is surgery, radiation,
chemotherapy, antibody-blocking therapy, or a combination
of therapies. The most important advance in the manage-
ment of head and neck cancer has been the increasing role of
chemotherapy, or antibody-blocking therapy, for use in
conjunction with radiation therapy to achieve cure with
organ preservation [17, 18]. Despite these advances, survival
rates for head and neck cancer have improved little in the
past 50 years. Current treatments have significant functional
and cosmetic impact and significant attention is focused on
improving the quality of life of these patients [17].
Oral squamous cell carcinoma (OSCC) represents an
excellent model for both head and neck cancer and solid
malignancies in general. Nearly 85% of all malignancies
are of epithelial origin including the skin, oral cavity,
nasopharyngeal, laryngeal, lung, gastrointestinal, colon, and
bladder cancer [15]. OSCC is an aggressive malignancy
that invades local tissue, spreads to regional and distant
sites, and has an overall 5-year survival of 60% [15]. About
80% to 90% of OSCC overexpress a surface antigen
important to tumor growth and proliferation, epithelial
growth factor receptor (EGFR) [19]. Analogous surface
receptors exist on other solid tumors, making EGFR an
excellent model for investigation of antibody-based target-
ing of tumors. EGFR-blocking therapies have enjoyed
recent success as adjuvant treatment to radiation with
significant reduction in associated toxicity for patients
[18]. Detection of OSCC primary or recurrent tumors is
possible with direct visual inspection because of surface-
exposed location in the body. As a result of these factors,
OSCC has been the focus of several early studies of
nanotechnology.
Find a Role for Nanotechnology in Cancer
Management?
Nanotechnology appears poised to provide devices capable
of 1) sensitive and specific anatomic, molecular, and
biologic imaging; 2) selective therapy of tumors; and 3)
relatively low toxicity. The physical properties of several
nanostructures strongly suggest that these goals are attain-
able and will result in a significant improvement over the
current standard of care. Patients with head and neck cancer
require staging assessments, invasive treatments, and post-
treatment monitoring with physical examination and routine
imaging for 5 years. The mainstay of imaging modalities
for diagnosis and follow-up head and neck cancer patients
are MRI, CT, ultrasonography, and positron emission
tomography(PET). Thesetechniqueshavelimitedresolution
and cannot detect microscopic or molecular changes.
Further, interpretation of findings can be complicated by
difficult anatomy, edema or inflammation, scarring from
prior treatment, and loss of detail because of patient
movement or dental implants. False-positive findings can
occur on PETimaging because of inflammatoryor infectious
processes.Furthermore,theimagingtechniquesarequitepoor
fordetectionofsmallsurfacelesions.Definitivediagnosisstill
requires tissue diagnosis with biopsy or needle aspiration.
Intraoperative diagnosis of tumor at the surgical margins can
be difficult. Developing sensitive and specific noninvasive
molecular tests for staging, screening, and intraoperative
diagnosis would significantly improve patient care.
Currently available therapies for head and neck cancer
suffer significant limitations. In the head and neck, surgical
resection is limited by several adjacent important structures
such as the carotid artery, eye, and brain. Residual tumor
may be left behind near vital structures or because it has
spread beyond the surgical margin, making adjuvant treat-
ments necessary to achieve cure of the residual disease.
Radiation therapy has a high failure rate for advanced
tumors, and toxicity limits the amount that can be given to
one full course treatment. Chemotherapy in head and neck
cancer is limited to a supportive role in combination with
radiation. Nanotechnology may provide a new tool for
clinicians by offering the potential of molecular diagnostic
probes and novel therapeutic devices, such as photothermal
and magneto-thermal probes, drug- and gene-delivery
vectors, and radiation enhancers.
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Three properties of gold nanoparticles are important at the
biologic level. First, the small size of the particles creates a
large surface area to volume. Based on the large surface
area, chemical reactions occur on the surface of the
nanoparticles at a significantly increased rate, creating
actively enhanced catalytic agents. The catalytic properties
have not yet found application in cancer therapy. Second,
nanoparticles happen to be the correct size for intravascular
transport and accumulation inside many tumor beds for
selective tumor targeting and drug delivery. Third, gold
particles take on optical properties useful for imaging and
photothermal therapy.
Gold Nanoparticles as a Drug-Delivery Vector
When hidden from the human immune system, gold
nanoparticles ranging from 10 nm to 140 nm will
accumulate inside tumors because of the enhanced
permeability and retention effect [20]. Passivating the
nanoparticle surface can be easily achieved with polymers
such as polyethylene glycol (PEG). Accumulation in solid
tumors occurs because of filtration through the poorly
formed, leaky vasculature associated with tumor angio-
genesis [20]. Paciotti et al. [8] demonstrated PEG bound
gold conjugated with TNF rapidly accumulated in MC-38
colon carcinoma tumor-bearing mice with little uptake in
other organs [8]. The PEG coating shields the complex
from the immune responses and is vital for successful drug
delivery. Paciotti et al. [8] discovered gold nanoparticles
with targeting ligands lacking a passivating agent are
taken up within minutes by the reticuloendothelial system.
Because gold readily bonds to sulfur atoms, gold nano-
particles can be easily conjugated to a range of molecules
through thiol chemistry. Loading gold with toxic chem-
icals or molecules, such as TNF, allows selective delivery
of large doses of toxins. By adding PEG in addition to
selected toxins, selective accumulation in the tumor
reduces toxicity of the treatment drug by avoiding the
other healthy host organs. Interestingly, the targeting
ligand TNF appears to increase uptake of the gold into
the tumor, suggesting that active ligands can improve
selective tumor targeting. As a result of these findings,
gold-based drug delivery is the first NIH funded human
“nano” trial initiated and has completed patient accumu-
lation in its phase 1 trial [21]. Several potential targeting
ligands exist to improve tumor uptake including folate,
transferrin, arginine–glycine–aspartic acid peptide, anti-
bodies, or antibody fragments to cell surface receptors
[22].
Optical Properties of Gold Useful for Imaging
and Therapy
Plasmons
Noble metal nanoparticles such as solid gold, silver, and
silica-core gold nanoshells exhibit dramatic optical proper-
ties useful for ultrasensitive sensing and photothermal
therapy. When stimulated by light, all the conduction band
electrons in the gold nanoparticles oscillate coherently on
the particle surface, creating a phenomena known as the
surface plasmon resonance (SPR). According to the Mie
theory, when light strikes gold nanoparticles smaller than
200 nm, energy is lost due to two processes: light scattering
and light absorption [6].
Light scattering occurs as energy from the light
stimulates the electrons on the particle surface to oscillate
and subsequently emit photons at the same frequency
(color) or at a shifted frequency. When light is absorbed,
the energy is converted efficiently into heat. The nano-
particles have a particular (resonance) frequency, or color,
in which they scatter and absorb the maximum amount of
light. The “peak frequency” is sensitive to the size, shape,
composition and surrounding environment. By changing
the size or shape, gold nanoparticles are tunable over the
visible and infrared region of light. Particles 30 nm to
100 nm in size scatter intensely and can be detected by
commercial microscopes with darkfield illumination. Using
a darkfield microscope, particles 40 nm in size can be
detected by eye at a concentration of 10
−14 M. A single
60 nm nanosphere is 10
5 times brighter than a fluorescein
molecule [3, 23]. Changing the electric field of the nano-
particles, such as by bringing two particles in close proximity
to each other, changes the peak frequency by shifting the
color toward the red region. A few nanoparticles will cause a
shift of a few nanometers, whereas aggregation of several
particles causes a larger red shift of up to 100 nm. If the
nanoparticle is coated with a substance, such as an antibody,
the light must pass through that substance, resulting in a
small red shift of the peak frequency. The attributes are
useful for plasmonic based imaging [3].
Plasmonic Cancer Imaging
In addition to direct interaction with light, the SPR creates a
source of energy on the particle surface that can affect
optical properties of molecules on its surface. Gold
nanotechnology appears useful for biomedical imaging in
many optical domains including fluorescence [24], light
absorption and scattering [4, 25, 26], photoacoustic
imaging [27], photothermal imaging [28], and surface-
enhanced Raman scattering [29]. Based on the SPR,
diagnostic imaging with gold nanospheres and nanorods
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multiphoton imaging of single nanorods [30], photoacoustic
imaging of tumors and sentinel nodes [31, 32], near
infrared absorption imaging [7•, 33], surface-enhanced
Raman spectroscopy [34••], and confocal endoscopy [35].
As optical sensors, gold nanoparticles are multifunction-
al probes that provide several new types of information for
medical imaging at the subcellular, biochemical, and
molecular level. Silica-gold nanoshells and solid gold
nanoparticles, as spheres and rods, can be selectively
targeted to OSCC using antibodies directed against EGFR.
Sokolov et al. [26] demonstrated in vitro immunoconju-
gated gold nanospheres are intense contrast agents using a
red laser pointer with a portable confocal endoscopy unit.
El-Sayed et al. [25] demonstrated the colorimetric attributes
of immunotargeted gold nanoparticles for imaging anatom-
ic location and molecular sensing of OSCC with light
scattering and absorption. Imaging of gold nanospheres
revealed colored particles with much greater affinity for the
malignant cell lines. Particles about 25 nm in size could
easily be detected above the background scattering of the
cellular components. Light absorption was measured from
single cells revealing characteristic absorption spectra of the
gold nanospheres. The authors reported measurement of a
shift in the color frequency by approximately 10 nm when
the antibody-gold conjugated bound the EGFR. Further-
more, the amount of nanoparticles on the cell surface could
be quantified as binding to the malignant cell line is 600%
more than to the control cells, consistent with expected
values of overexpression of EGFR on the cell lines [25].
Huang et al. [4] subsequently demonstrated gold nanorods
as near-infrared (NIR) imaging probes in the same OSCC
cell line model using light scattering and absorption.
Plasmonic imaging was subsequently performed in vivo
using light scattering. The authors found about a 100 nm
red shift of the particles color (from green to red) on the cell
surface. The imaging characteristics and color change are
thought to be caused by the aggregation of the nano-
particles induced by the clustering of overexpressed EGFR
on the cancer cell surface.
Fluorescence Imaging of Gold Nanoparticles
The SPR can further enhance other optical processes of
molecules in close proximity to the nanoparticles. For
instance, gold nanoparticles quench fluorescence of mole-
cules when covalently bound to the molecule, but enhance
the scattering and fluorescence of molecules on their
surface is separated from the nanoparticles by a distance
sufficient to minimize quenching. In OSCC cell culture
models, El-Sayed et al. [24] found that gold nanoparticles
quench cellular autofluorescence approximately 15% when
incubated or immunoconjugated to cells. This effect was
interpreted to be due to intense light absorption of the
particles that were restricted in cellular compartments from
accessing strong cellular fluorophores.
Molecular Detection with Surface-enhanced
Raman Scattering
Surface-enhanced Raman scattering (SERS) is a powerful
technology potentially useful for single-cell study and
clinical medical diagnostics in vivo. Raman scattering of
light occurs as a result of modulating the scattered light by
the vibrational frequencies of the irradiated molecules. This
produces a so-called fingerprint spectrum specific to the
molecule. Because of the typically weak signals, use of
Raman spectroscopy has been limited in medical applica-
tions. However, the gold SPR strongly enhances Raman
scattering of adjacent molecules, creating a surface-
enhanced Raman spectroscopy, known as SERS. Gold
SPR enhances the Raman scattering by orders of magnitude
(more than a million times) [34] and has been reported for
the use of SERS for single molecule detection [36] and in
vivo detection of cancer in a murine model. Gold nano-
spheres tagged with colored dyes and covalently bound to
anti-EGFR single chain variable fragment (Sc-Fv) B10
antibodies produced strong SERS spectra of the dyes using
a 20 mW laser at 9 mm from the skin. The dyes were 200
times brighter than the fluorescence emitted by the
comparison group labeled with quantum dots [34]. Further-
more, SERS spectra have been obtained from nanoparticles
targeted to the cytoplasm, nucleus [37], and cell surface
[38]. Huang et al. [38] identified a possible molecular
signature of EGFR overexpression using antibody-
conjugated gold nanorods. The anti-EGFR nanorod SERS
produced a strong, polarized spectra. The great intensity of
signals created by gold nanorods results from the over-
lapping gold plasmonic fields of the rods lined lengthwise
that would not occur with haphazard alignment on the cell
surface. The lengthwise arrangement of the nanorods is
postulated to result from tight packing of some of the rods
in close proximity because of overexpression, clustering,
and dimerization of EGFR receptors on the cancer cell
surface [38].
Plasmonic Photothermal Therapy
Another useful application of light absorption by gold
nanoparticles is generation of heat for plasmonic photo-
thermal therapy (PPTT). By changing the size, shape, or
composition of the nanoparticles, the color of light that
absorbs maximal energy can be tuned over the visible and
NIR spectra. The NIR region from 650 nm to 900 nm is a
desirable optical window in human tissue for deep
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across the visible spectrum, the nanoshells and nanorods
are both tunable across the NIR spectrum. The main
determining factor of nanorod peak absorption is the
aspect ratio of the particle: the relation of the length to
width. By changing the aspect ratio (ratio of the short end
to long end), gold nanorods are tunable over the near IR
region from 650 nm to 1000 nm, where tissue penetration
of human tissue by light is maximal. Although light
penetration of human tissue is limited to a few millimeters
in the visible region, microwatt laser NIR light can
p e n e t r a t e1 0c mi n t ob r e a s tt i s s u ea n d4c mi n t os k u l l /
brain or deep muscle tissue. Higher power US Food and
Drug Administration class 3 lasers can penetrate through
7 cm of muscle and neonatal skull/brain [39]. From a
surgeon’s perspective, in practical use, light delivery and
nanoparticle selection can be tailored to specific lesions.
Light and nanoparticles can be delivered externally, within
the tumor by intravascular canalization, direct needle-
guided placement, or into a postoperative field for residual
tumor cells.
Gold nanoshells, a first generation nanotechnology with
a silica core surrounded by a gold shell, have been
successfully tested in vitro [40, 41], in vivo in animal
models [42], and are currently initiating human trials for
NIR photothermal therapy in refractory head and neck
cancers [13]. However, based on modeling of heating
efficiencies of gold nanospheres, nanorods, nanoshells and
molecular dyes, gold nanorods seem to be far superior
agents [43].
Selective targeting with PPTT of OSCC was demon-
strated in vitro in the visible range with immunoconjugated
gold nanospheres [5]. Using a laser in the visible region at
442 nm, gold nanospheres were efficiently heated and killed
the cells in two malignant OSCC cell lines at 19 W/cm
2
(HOC 313 clone 8) and 25 W/cm
2 (HSC 3) at much lower
energy compared to the nonmalignant cell line (HaCat) at
57 W/cm
2 [5]. However, visible light only penetrates
human tissue on the order of a few millimeters and
nanospheres would be limited to surface applications.
By changing the shape to a rod, or using a nanoshell, the
peak absorption wavelength can be tuned to the NIR
spectrum. Gold nanoshells targeted to breast cancer [41]
and gold nanorods targeted to OSCC in the NIR [4] have
been reported for combined imaging and photothermal
therapy at 800 nm using a Ti:sapphire laser [4]. Nanorods
achieve tumoricidal effect with less energy than either
nanoshells or nanospheres. Nanoshells caused cell death at
35 W/cm
2 for 7 min exposure [41], whereas immunotar-
geted gold nanorods achieved cell death with 3 min
exposure at 10 W/cm
2 in vitro [7].
Based on heating and modeling experiments, gold
nanoparticles can generate temperatures of 70°C to 80°C
in these cells using far lower laser powers than conven-
tional dyes [44]. Temperatures of 70°C to 80°C celsius are
hot enough to denature proteins and disrupt protein, DNA,
and RNA. Image analysis suggest cell death occurs because
of blebbing formation of the cell wall and loss of membrane
integrity [45]. Cell injury is likely related to both necrosis
and cell membrane rupture.
Comparison of gold nanospheres, nanorods, and nano-
shells reveals the gold nanoparticles absorb light at 10
4
times better than the best molecular dyes. Gold nanorods
absorb a similar amount of energy as gold nanoshells at one
third the size because the entire nanorod is composed of
gold [43]. Furthermore, nanorods absorb the most energy
per particle volume of all the particles. To compare particles
across a range of sizes, a volumetric coefficient, expressed
as a per micron absorption coefficient uabs can be
calculated. Examining the nanoshell configuration used in
vivo for photothermal trials (inner core, 60 nm; outer core,
70 nm) [40, 41], the nanoshells have a uabs of 35.62 with a
peak absorption at 892 nm. At 11.4 nm, the nanorods uabs=
1000.87 at 863 nm, roughly 30 times more than the
nanoshells (Table 1)[ 43].
Both nanorods and nanoshells are tested in vivo with
PPTT. Hirsch et al. [41] found a maximal temperature rise
of 37°C using 4 to 6 min of laser exposure in a murine
model of transmissible venereal tumor with 10- to 25-fold
less laser energy than needed for indocyanine green dye
[41]. In an OSCC murine model, PEGylated nanorods were
successfully imaged in OSCC implanted murine tumors
using an infrared light source and charge coupled device
Table 1 Comparison of absorption coefficient of nanorods and
nanoshells
Particle
a Dimension λmaxnm μа
Silica-gold R1=40 nm 843 50.61
R2=70 nm
Silica-gold R1=50 nm 704 20.57
R2=70 nm
Silica-gold R1=90 nm 984 11.07
R2=105 nm
Nanorods AR=3.1, reff=11.43 nm 797 907.09
Nanorods AR=3.9, reff=11.43 nm 863 1003.87
Nanorods AR=3.9, reff=8.74 nm 788 986
Nanorods AR=3.9, reff=21.86 nm 842 449.34
aGold nanorods have about 30 times more absorption of light in the
size range of particles under study for photothermal applications.
AR aspect ratio; λmax wavelength where particle has maximal
absorption and scattering (extinction); μа per micron absorption
coefficient; R1 outer gold core; R2 inner silica core; reff effective
radius of nanorod.
(Adapted from Jain et al. [43], with permission.)
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laser with a 6 mm beam achieved a 22°C temperature rise
and a 25% (intravenous route) and 57% (direct injection
into tumor) reduction of tumor compared with the sham
treatment group after 13 days. Imaging revealed the direct
injection group had 2.18 times greater absorption of light in
the tumor than the intravenous injection group and 4.35
greater than the control group at 2 min (Fig. 1).
The biodistribution of gold nanorods appears similar to
other nanoparticles and can be delivered intravascularly to
tumors. In vivo mice studies demonstrated PEG-nanorods
accumulates about one third of the gold in the tumor [9,
46], making gold nanorods very attractive for PPTT
applications in the head and neck.
Radiation Enhancement
Gold nanotechnology is potentially useful to augment
current ionizing radiation techniques through two ave-
nues: tissue hyperthermia and radiation enhancement.
Gold is strong absorber of radiographs. Hainfeld et al.
[47] calculated that radiation doses could be enhanced
locally around gold nanoparticles loaded into tumors by
more than 200%. Tumor-burdened mice treated with gold
nanoparticles and radiation demonstrated 86% 1-year
survival in gold nanoparticle treatment group compared
with only 20% in group treated with radiation alone [11].
In addition, the effectiveness of ionizing radiation can be
improved with local tissue hyperthermia during treatment.
This effect can be achieved using photothermal techniques
[48].
Other Technologies
Other nanotechnologies clearly have significant potential
for application in the diagnosis and management of head
and neck cancer, such as carbon nanotubes, iron oxide
(magnetic) nanoparticles, and dendrimers [2, 22, 49]. For
instance, iron-based nanoparticles work on similar princi-
ples to gold nanoparticles as magnetically active probes for
imaging, therapy, and drug carrying [49]. A variety of
additional ligands have been attached to nanoparticles to
selectively target cancer cells. Other classes of nano-
particles can serve as drug or gene carries. As later
generations of nanotechnology develop, such as combined
magnetico-optico particles [50], integrated particles com-
prising “nanosystems” are expected to be developed
capable of performing complex actions.
Conclusions
Nanotechnology is poised to create a paradigm shift in the
diagnosis and management of head and neck cancer
through the creation of multifunctional devices capable
of sensitive, specific diagnosis and simultaneous therapy.
Whereas several nanoparticles have been developed,
plasmonic gold nanoparticles appear particularly interest-
ing because of their facile surface chemistry, relatively
limited toxicity, and novel optical properties useful for
concurrent imaging and therapy. Gold nanotechnology
brings forth ultrasensitive optical imaging and multiple
therapeutic options that may be potentially used in
unison. As a drug delivery agent, toxicity of attached
drugs is significantly reduced. Photothermal therapy adds
a new treatment that can be used in addition to other
forms of treatment. Enhancement of radiation could
significantly improve delivery of appropriate radiation
doses with reduced toxicity to surrounding tissue.
Although much work is still required to understand the
toxicity and best applications, compared with the limi-
tations and toxicities of existing treatment, nanotechnol-
ogy may significantly advance management of head and
neck cancer.
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Fig. 1 Near infrared absorption imaging with gold nanorods in mice
treated with tumors (top). Extinction spectra (bottom) reveal that direct
injection achieves nearly twice the absorption of intravascular
injection of the nanorods. PBS—phosphate buffered saline. (From
Dickerson et al. [7•], with permission.)
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